🚀 VC round data is live in beta, check it out!

Ems-Chemie Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ems-Chemie and similar public comparables like Industries Qatar, SABIC Agri-Nutrient, Borouge, DuPont and more.

Ems-Chemie Overview

About Ems-Chemie

Ems-Chemie Holding AG is a holding company that, through its subsidiaries, manufactures and sells a variety of chemical-based products. The firm organizes itself into two segments based on product type: High-Performance Polymers and Specialty Chemicals. The High-Performance Polymers segment, which generates the majority of revenue, sells plastic products to the automotive, electrical, and electronics industries. The Specialty Chemicals segment sells fibres, bonding agents for tires, and fusible bonding yarns for textiles and powder coating products. Geographically, the majority of its revenue comes from Europe and the rest from Asia, the Americas, and other regions.


Founded

1962

HQ

Switzerland

Employees

2.8K

Sectors

Financials (LTM)

Revenue: $3B
EBITDA: $805M

EV

$19B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ems-Chemie Financials

Ems-Chemie reported last 12-month revenue of $3B and EBITDA of $805M.

In the same LTM period, Ems-Chemie generated $801M in gross profit, $805M in EBITDA, and $610M in net income.

Revenue (LTM)


Ems-Chemie P&L

In the most recent fiscal year, Ems-Chemie reported revenue of $3B and EBITDA of $800M.

Ems-Chemie expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Ems-Chemie forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$3BXXX$3BXXXXXXXXX
Gross Profit$801MXXX$1BXXXXXXXXX
Gross Margin32%XXX49%XXXXXXXXX
EBITDA$805MXXX$800MXXXXXXXXX
EBITDA Margin32%XXX32%XXXXXXXXX
EBIT Margin29%XXX29%XXXXXXXXX
Net Profit$610MXXX$602MXXXXXXXXX
Net Margin24%XXX24%XXXXXXXXX

Financial data powered by Morningstar, Inc.

Ems-Chemie Stock Performance

Ems-Chemie has current market cap of $20B, and enterprise value of $19B.

Market Cap Evolution


Ems-Chemie's stock price is $861.85.

See Ems-Chemie trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$19B$20B0.7%XXXXXXXXX$25.76

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ems-Chemie Valuation Multiples

Ems-Chemie trades at 7.7x EV/Revenue multiple, and 24.1x EV/EBITDA.

See valuation multiples for Ems-Chemie and 15K+ public comps

EV / Revenue (LTM)


Ems-Chemie Financial Valuation Multiples

As of April 18, 2026, Ems-Chemie has market cap of $20B and EV of $19B.

Equity research analysts estimate Ems-Chemie's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Ems-Chemie has a P/E ratio of 33.1x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$20BXXX$20BXXXXXXXXX
EV (current)$19BXXX$19BXXXXXXXXX
EV/Revenue7.7xXXX7.7xXXXXXXXXX
EV/EBITDA24.1xXXX24.3xXXXXXXXXX
EV/EBIT26.5xXXX26.6xXXXXXXXXX
EV/Gross Profit24.2xXXX15.7xXXXXXXXXX
P/E33.1xXXX33.5xXXXXXXXXX
EV/FCF30.1xXXX29.8xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ems-Chemie Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ems-Chemie Margins & Growth Rates

Ems-Chemie's revenue in the last 12 month grew by 1%.

Ems-Chemie's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.2M for the same period.

Ems-Chemie's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ems-Chemie's rule of X is 35% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Ems-Chemie and other 15K+ public comps

Ems-Chemie Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth1%XXX(0%)XXXXXXXXX
EBITDA Margin32%XXX32%XXXXXXXXX
EBITDA Growth3%XXX2%XXXXXXXXX
Rule of 40—XXX33%XXXXXXXXX
Bessemer Rule of X—XXX35%XXXXXXXXX
Revenue per Employee—XXX$0.9MXXXXXXXXX
Opex per Employee—XXX$0.2MXXXXXXXXX
G&A Expenses to Revenue—XXX2%XXXXXXXXX
Opex to Revenue—XXX20%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ems-Chemie Public Comps

See public comps and valuation multiples for other Chemicals comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Ems-ChemieXXXXXXXXXXXXXXXXXX
Industries QatarXXXXXXXXXXXXXXXXXX
SABIC Agri-NutrientXXXXXXXXXXXXXXXXXX
BorougeXXXXXXXXXXXXXXXXXX
DuPontXXXXXXXXXXXXXXXXXX
International Flavors & FragrancesXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Ems-Chemie M&A Activity

Ems-Chemie acquired XXX companies to date.

Last acquisition by Ems-Chemie was on XXXXXXXX, XXXXX. Ems-Chemie acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Ems-Chemie

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Ems-Chemie Investment Activity

Ems-Chemie invested in XXX companies to date.

Ems-Chemie made its latest investment on XXXXXXXX, XXXXX. Ems-Chemie invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Ems-Chemie

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ems-Chemie

When was Ems-Chemie founded?Ems-Chemie was founded in 1962.
Where is Ems-Chemie headquartered?Ems-Chemie is headquartered in Switzerland.
How many employees does Ems-Chemie have?As of today, Ems-Chemie has over 2K employees.
Who is the CEO of Ems-Chemie?Ems-Chemie's CEO is Magdalena Martullo.
Is Ems-Chemie publicly listed?Yes, Ems-Chemie is a public company listed on SIX Swiss Exchange.
What is the stock symbol of Ems-Chemie?Ems-Chemie trades under EMSN ticker.
When did Ems-Chemie go public?Ems-Chemie went public in 2010.
Who are competitors of Ems-Chemie?Ems-Chemie main competitors are Industries Qatar, SABIC Agri-Nutrient, Borouge, DuPont.
What is the current market cap of Ems-Chemie?Ems-Chemie's current market cap is $20B.
What is the current revenue of Ems-Chemie?Ems-Chemie's last 12 months revenue is $3B.
What is the current revenue growth of Ems-Chemie?Ems-Chemie revenue growth (NTM/LTM) is 1%.
What is the current EV/Revenue multiple of Ems-Chemie?Current revenue multiple of Ems-Chemie is 7.7x.
Is Ems-Chemie profitable?Yes, Ems-Chemie is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Ems-Chemie?Ems-Chemie's last 12 months EBITDA is $805M.
What is Ems-Chemie's EBITDA margin?Ems-Chemie's last 12 months EBITDA margin is 32%.
What is the current EV/EBITDA multiple of Ems-Chemie?Current EBITDA multiple of Ems-Chemie is 24.1x.
What is the current FCF of Ems-Chemie?Ems-Chemie's last 12 months FCF is $645M.
What is Ems-Chemie's FCF margin?Ems-Chemie's last 12 months FCF margin is 26%.
What is the current EV/FCF multiple of Ems-Chemie?Current FCF multiple of Ems-Chemie is 30.1x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial